Invention Grant
- Patent Title: Modified-dextrans for use in optical glucose assays
-
Application No.: US15581416Application Date: 2017-04-28
-
Publication No.: US10543288B2Publication Date: 2020-01-28
- Inventor: Tri T. Dang , Soren Aasmul , Jesper Svenning Kristensen , Joseph Hanna , Robert McKinlay
- Applicant: Medtronic MiniMed, Inc.
- Applicant Address: US CA Northridge
- Assignee: MEDTRONIC MINIMED, INC.
- Current Assignee: MEDTRONIC MINIMED, INC.
- Current Assignee Address: US CA Northridge
- Agency: Gates & Cooper LLP
- Main IPC: A61K49/00
- IPC: A61K49/00

Abstract:
The invention is directed to a competitive glucose binding affinity assay comprising a glucose receptor (typically mannan binding lectin) labeled with an assay fluorophore and a modified glucose analog (typically dextran) labeled with a reference fluorophore. In certain embodiments, the glucose analog is dextran and is coupled to both a reference fluorophore and a quencher dye (e.g. hexamethoxy crystalviolet-1). Optionally the reference fluorophore is blue shifted relative to the assay fluorophore.
Public/Granted literature
- US20180311382A1 MODIFIED-DEXTRANS FOR USE IN OPTICAL GLUCOSE ASSAYS Public/Granted day:2018-11-01
Information query